AuditorOct 20, 2026, 06:06 AM
Annovis Bio Corrects Audit Fee Disclosure
AI Summary
Annovis Bio, Inc. filed a Form 8-K to correct a typographical error in its proxy statement regarding audit fees for its annual meeting of stockholders held on June 17, 2026. The filing provides the corrected figures for audit fees and audit-related fees for the years 2025 and 2024, with Ernst & Young LLP as the auditor.
Key Highlights
- Annovis Bio corrects audit fees in proxy statement for June 17, 2026 annual meeting.
- Corrected Audit Fees for 2025: $415,000 (Ernst & Young LLP).
- Corrected Audit Fees for 2024: $375,000 (Ernst & Young LLP).
- Corrected Audit-Related Fees for 2025: $100,000.
- Corrected Audit-Related Fees for 2024: $107,045.
- Total Fees for 2025: $515,000.
- Total Fees for 2024: $482,045.
Price Impact
More from ANVS